Protagonist Therapeutics Inc. (PTGX) NASDAQ
$24.86 (0.85) (-3.29%)
Market Cap: $1.50B
As of 04/25/24 10:59 AM EDT. Market open.
Protagonist Therapeutics Inc. (PTGX)
NASDAQ
$24.86
(0.85) (-3.29%)
Market Cap: $1.50B
As of 04/25/24 10:59 AM EDT. Market open.
Add to Portfolio
protagonist therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform which is utilized to discover and develop novel peptide-based drugs to address significant unmet medical needs. its primary focus is on developing potential first-in-class oral targeted therapy-based peptide drugs that work by blocking biological pathways that are currently targeted by ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$520,000
CEO Compensation (Total)
$3.72M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
99
CEO Compensation (Base)
$520,000
CEO Compensation (Total)
$3.72M
Address
.
PRICE CHART FOR PROTAGONIST THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$25.12
Previous Close
$25.70
Days Range
$25.62 - $27.14
52 week range
$13.72 - $33.34
Volume
95,810
Avg. Volume (30 days)
541,560
Market Cap
$1.50B
Dividend Yield
-
P/E
-
Shares Outstanding
58,274,998
Open
$25.12
Previous Close
$25.70
Days Range
$25.62 - $27.14
52 week range
$13.72 - $33.34
Volume
95,810
Avg. Volume (30 days)
541,560
Market Cap
$1.50B
Dividend Yield
-
P/E
-
Shares Outstanding
58,274,998
FINANCIAL STATEMENTS FOR PROTAGONIST THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR PROTAGONIST THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Ali Asif | Chief Financial Officer | Apr 18, 2024 | Sale | $25.11 | 1,234 | 30,986 | 37,163 | Apr 19, 2024, 08:05 PM |
PATEL DINESH V PH D | President and CEO | Apr 01, 2024 | Sale | $28.31 | 25,000 | 707,750 | 549,590 | Apr 02, 2024, 08:29 PM |
SELICK HAROLD E | Director | Mar 07, 2024 | Option Exercise | $1.89 | 6,490 | 12,266 | 27,996 | Mar 11, 2024, 08:00 PM |
PATEL DINESH V PH D | President and CEO | Mar 01, 2024 | Sale | $31.62 | 30,000 | 948,600 | 574,590 | Mar 01, 2024, 08:46 PM |
Waddill William D. | Director | Mar 01, 2024 | Option Exercise | $6.09 | 12,975 | 79,018 | 24,975 | Mar 01, 2024, 08:45 PM |
Waddill William D. | Director | Mar 01, 2024 | Sale | $31.34 | 12,975 | 406,637 | 12,000 | Mar 01, 2024, 08:45 PM |
Ali Asif | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $12.17 | 12,000 | 146,040 | 52,645 | Mar 01, 2024, 08:45 PM |
Ali Asif | Chief Financial Officer | Mar 01, 2024 | Sale | $32.24 | 14,248 | 459,318 | 40,645 | Mar 01, 2024, 08:45 PM |
Ali Asif | Chief Financial Officer | Feb 29, 2024 | Sale | $30.69 | 9,939 | 305,048 | 42,734 | Mar 01, 2024, 08:45 PM |
PATEL DINESH V PH D | President and CEO | Feb 26, 2024 | Option Exercise | $29.53 | 10,915 | 322,320 | 604,590 | Feb 28, 2024, 08:02 PM |
Gupta Suneel | Chief Development Officer | Feb 26, 2024 | Option Exercise | $29.53 | 4,282 | 126,447 | 183,285 | Feb 28, 2024, 08:00 PM |
PATEL DINESH V PH D | President and CEO | Feb 15, 2024 | Option Exercise | $28.23 | 3,717 | 104,931 | 615,505 | Feb 20, 2024, 08:00 PM |
MOLINA ARTURO MD | Chief Medical Officer | Jan 16, 2024 | Option Exercise | $24.63 | 427 | 10,517 | 48,350 | Jan 18, 2024, 08:00 PM |
Ali Asif | Chief Financial Officer | Jan 16, 2024 | Option Exercise | $24.63 | 1,452 | 35,763 | 50,584 | Jan 18, 2024, 08:00 PM |
Gupta Suneel | Chief Development Officer | Jan 09, 2024 | Option Exercise | $7.38 | 5,000 | 36,900 | 192,567 | Jan 11, 2024, 08:00 PM |
Gupta Suneel | Chief Development Officer | Jan 09, 2024 | Sale | $25.00 | 5,000 | 125,000 | 187,567 | Jan 11, 2024, 08:00 PM |
MOLINA ARTURO MD | Chief Medical Officer | Nov 15, 2023 | Sale | $16.24 | 1,848 | 30,012 | 22,527 | Jan 04, 2024, 08:09 PM |
PATEL DINESH V PH D | President and CEO | Dec 13, 2023 | Sale | $20.08 | 75,000 | 1,506,000 | 534,347 | Dec 15, 2023, 04:30 PM |
Gupta Suneel | Chief Development Officer | Oct 19, 2023 | Option Exercise | $7.38 | 20,000 | 147,600 | 168,317 | Oct 23, 2023, 04:31 PM |
PATEL DINESH V PH D | President and CEO | Oct 18, 2023 | Option Exercise | $4.21 | 6,000 | 25,260 | 609,347 | Oct 19, 2023, 04:55 PM |
Gupta Suneel | Chief Development Officer | May 31, 2023 | Option Exercise | $26.07 | 4,150 | 108,190 | 148,037 | Jun 02, 2023, 07:51 PM |
PATEL DINESH V PH D | President and CEO | May 31, 2023 | Option Exercise | $26.07 | 12,165 | 317,142 | 602,946 | Jun 02, 2023, 07:50 PM |
Ali Asif | Chief Financial Officer | May 31, 2023 | Option Exercise | $26.07 | 4,150 | 108,190 | 31,036 | Jun 02, 2023, 07:48 PM |
Ali Asif | Chief Financial Officer | Apr 18, 2023 | Option Exercise | $23.21 | 1,189 | 27,597 | 23,186 | Apr 19, 2023, 04:28 PM |
SELICK HAROLD E | Director | Apr 10, 2023 | Option Exercise | $0.87 | 6,196 | 5,391 | 21,506 | Apr 11, 2023, 07:18 PM |
Liu David Y | Chief R&D Strategy Officer | Nov 16, 2022 | Option Exercise | $2.31 | 100,479 | 231,802 | 167,590 | Nov 17, 2022, 06:24 PM |
PATEL DINESH V PH D | President and CEO | Aug 23, 2022 | Option Exercise | $4.21 | 20,000 | 84,200 | 604,048 | Aug 24, 2022, 06:15 PM |
Waddill William D. | Director | May 03, 2022 | Option Exercise | $8.59 | 12,000 | 103,080 | 12,000 | May 04, 2022, 08:41 PM |
PATEL DINESH V PH D | President and CEO | May 04, 2022 | Option Exercise | $4.21 | 15,742 | 66,274 | 584,048 | May 04, 2022, 08:33 PM |
Gupta Suneel | Chief Development Officer | Apr 26, 2022 | Option Exercise | $7.38 | 40,000 | 295,200 | 117,561 | Apr 26, 2022, 09:42 PM |
PATEL DINESH V PH D | President and CEO | Apr 26, 2022 | Option Exercise | $4.21 | 30,000 | 126,300 | 568,306 | Apr 26, 2022, 09:34 PM |
PATEL DINESH V PH D | President and CEO | Apr 14, 2022 | Option Exercise | $1.89 | 34,087 | 64,424 | 537,847 | Apr 14, 2022, 08:09 PM |
Gupta Suneel | Chief Development Officer | Feb 28, 2022 | Option Exercise | $24.28 | 649 | 15,758 | 77,007 | Mar 02, 2022, 08:40 PM |
PATEL DINESH V PH D | President and CEO | Feb 28, 2022 | Option Exercise | $24.28 | 4,648 | 112,853 | 503,760 | Mar 02, 2022, 08:39 PM |
Liu David Y | Chief Scientific Officer | Feb 28, 2022 | Option Exercise | $24.28 | 2,119 | 51,449 | 66,538 | Mar 02, 2022, 08:38 PM |
PATEL DINESH V PH D | President and CEO | Dec 21, 2021 | Sale | $32.14 | 15,000 | 482,170 | 477,158 | Dec 23, 2021, 04:17 PM |
PATEL DINESH V PH D | President and CEO | Sep 21, 2021 | Option Exercise | $4.21 | 40,000 | 168,400 | 492,158 | Sep 21, 2021, 09:45 PM |
Liu David Y | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $0.87 | 10,000 | 8,700 | 73,033 | Aug 19, 2021, 05:49 PM |
Liu David Y | Chief Scientific Officer | Aug 17, 2021 | Sale | $47.56 | 14,779 | 702,889 | 58,254 | Aug 19, 2021, 05:49 PM |
Noonberg Sarah B. | Director | Feb 10, 2021 | Option Exercise | $6.98 | 4,700 | 32,806 | 4,700 | Feb 12, 2021, 06:36 PM |
Noonberg Sarah B. | Director | Feb 11, 2021 | Option Exercise | $6.98 | 3,700 | 25,826 | 3,700 | Feb 12, 2021, 06:36 PM |
Noonberg Sarah B. | Director | Feb 10, 2021 | Sale | $25.47 | 4,700 | 119,722 | 400 | Feb 12, 2021, 06:36 PM |
Noonberg Sarah B. | Director | Feb 11, 2021 | Sale | $25.09 | 3,700 | 92,833 | 0 | Feb 12, 2021, 06:36 PM |
PATEL DINESH V PH D | President and CEO | Jan 19, 2021 | Option Exercise | $4.21 | 13,000 | 54,730 | 450,990 | Jan 20, 2021, 08:20 PM |
PATEL DINESH V PH D | President and CEO | Jan 19, 2021 | Sale | $24.60 | 24,846 | 611,105 | 426,144 | Jan 20, 2021, 08:20 PM |
KHOSLA CHAITAN PHD | Director | Aug 11, 2020 | Option Exercise | $1.89 | 2,499 | 4,723 | 2,499 | Aug 12, 2020, 05:38 PM |
KHOSLA CHAITAN PHD | Director | Aug 11, 2020 | Sale | $17.19 | 2,499 | 42,952 | 0 | Aug 12, 2020, 05:38 PM |
PATEL DINESH V PH D | President and CEO | Mar 20, 2020 | Option Exercise | $1.89 | 10,000 | 18,900 | 439,990 | Mar 23, 2020, 06:14 PM |
PATEL DINESH V PH D | President and CEO | Mar 12, 2020 | Option Exercise | $1.16 | 18,344 | 21,279 | 429,990 | Mar 13, 2020, 01:04 PM |
SELICK HAROLD E | Director | Mar 12, 2020 | Buy | $6.70 | 12,000 | 80,400 | 15,310 | Mar 12, 2020, 07:26 PM |
Giraudo Bryan | Director | Dec 03, 2019 | Buy | $5.70 | 8,000 | 45,620 | 8,000 | Dec 03, 2019, 06:46 PM |
Gupta Suneel | EVP Clinical Operations | Dec 03, 2019 | Buy | $5.13 | 30,000 | 153,900 | 49,500 | Dec 03, 2019, 06:32 PM |
Kalkofen Donald A. | Chief Financial Officer | Dec 03, 2019 | Buy | $5.10 | 1,175 | 5,987 | 1,175 | Dec 03, 2019, 06:11 PM |
PATEL DINESH V PH D | President and CEO | Dec 03, 2019 | Buy | $5.62 | 30,000 | 168,500 | 409,824 | Dec 03, 2019, 06:10 PM |
PATEL DINESH V PH D | President and CEO | Nov 26, 2019 | Option Exercise | $1.16 | 4,000 | 4,640 | 379,824 | Nov 27, 2019, 02:58 PM |
Liu David Y | Chief Scientific Officer | Aug 06, 2019 | Sale | $8.85 | 3,395 | 30,044 | 49,802 | Aug 08, 2019, 06:17 PM |
PATEL DINESH V PH D | President and CEO | Aug 06, 2019 | Sale | $8.85 | 10,792 | 95,535 | 374,792 | Aug 08, 2019, 06:15 PM |
SELICK HAROLD E | Director | Apr 01, 2019 | Option Exercise | $1.31 | 3,310 | 4,336 | 3,310 | Apr 02, 2019, 07:19 PM |
Liu David Y | Chief Scientific Officer | Mar 01, 2019 | Sale | $8.03 | 810 | 6,504 | 51,197 | Mar 04, 2019, 06:35 PM |
PATEL DINESH V PH D | President and CEO | Mar 01, 2019 | Sale | $8.03 | 2,183 | 17,529 | 383,831 | Mar 04, 2019, 06:33 PM |
Shames Richard S. | Chief Medical Officer | Mar 01, 2019 | Sale | $8.03 | 657 | 5,276 | 32,021 | Mar 04, 2019, 06:29 PM |
PATEL DINESH V PH D | President and CEO | Feb 06, 2019 | Sale | $7.74 | 10,909 | 84,410 | 367,396 | Feb 08, 2019, 05:37 PM |
Liu David Y | Chief Scientific Officer | Feb 06, 2019 | Sale | $7.74 | 3,821 | 29,562 | 37,007 | Feb 08, 2019, 05:30 PM |
Shames Richard S. | Chief Medical Officer | Feb 06, 2019 | Sale | $7.74 | 2,778 | 21,506 | 26,758 | Feb 08, 2019, 05:27 PM |
PATEL DINESH V PH D | President and CEO | Jan 11, 2019 | Option Exercise | $1.16 | 22,344 | 25,919 | 368,173 | Jan 14, 2019, 07:00 PM |
CANAAN X L.P. | 10% Owner | May 17, 2018 | Sale | $6.09 | 38,968 | 237,358 | 2,116,552 | May 21, 2018, 04:34 PM |
Giraudo Bryan | Director | May 16, 2017 | Buy | $6.46 | 10,000 | 64,566 | 10,000 | May 17, 2018, 05:48 PM |
CANAAN X L.P. | 10% Owner | May 14, 2018 | Sale | $6.37 | 77,591 | 494,224 | 2,242,676 | May 16, 2018, 05:16 PM |
CANAAN X L.P. | 10% Owner | May 16, 2018 | Sale | $6.46 | 29,441 | 190,071 | 2,155,520 | May 16, 2018, 05:16 PM |
CANAAN X L.P. | 10% Owner | May 15, 2018 | Sale | $6.48 | 57,715 | 374,080 | 2,184,961 | May 16, 2018, 05:16 PM |
PATEL DINESH V PH D | President and CEO | May 10, 2018 | Option Exercise | $1.16 | 13,516 | 15,679 | 265,779 | May 11, 2018, 06:50 PM |
PATEL DINESH V PH D | President and CEO | Apr 02, 2018 | Option Exercise | $1.16 | 20,000 | 23,200 | 252,263 | Apr 03, 2018, 05:17 PM |
PATEL DINESH V PH D | President and CEO | Mar 26, 2018 | Option Exercise | $0.87 | 11,298 | 9,829 | 232,263 | Mar 28, 2018, 05:20 PM |
CANAAN X L.P. | 10% Owner | Mar 23, 2018 | Sale | $20.71 | 59,950 | 1,241,325 | 2,320,267 | Mar 26, 2018, 04:25 PM |
CANAAN X L.P. | 10% Owner | Mar 21, 2018 | Sale | $20.61 | 17,699 | 364,727 | 2,384,976 | Mar 22, 2018, 05:33 PM |
CANAAN X L.P. | 10% Owner | Mar 20, 2018 | Sale | $20.61 | 17,060 | 351,538 | 2,402,675 | Mar 22, 2018, 05:33 PM |
CANAAN X L.P. | 10% Owner | Mar 22, 2018 | Sale | $20.62 | 4,759 | 98,133 | 2,380,217 | Mar 22, 2018, 05:33 PM |
CANAAN X L.P. | 10% Owner | Mar 19, 2018 | Sale | $20.57 | 13,439 | 276,446 | 2,419,735 | Mar 19, 2018, 05:22 PM |
CANAAN X L.P. | 10% Owner | Mar 16, 2018 | Sale | $20.51 | 6,926 | 142,063 | 2,433,174 | Mar 19, 2018, 05:22 PM |
CANAAN X L.P. | 10% Owner | Mar 13, 2018 | Sale | $20.84 | 1,204 | 25,094 | 2,452,051 | Mar 15, 2018, 04:55 PM |
CANAAN X L.P. | 10% Owner | Mar 15, 2018 | Sale | $20.64 | 11,751 | 242,521 | 2,440,100 | Mar 15, 2018, 04:55 PM |
CANAAN X L.P. | 10% Owner | Mar 14, 2018 | Sale | $20.77 | 200 | 4,154 | 2,451,851 | Mar 15, 2018, 04:55 PM |
Liu David Y | Chief Scientific Officer | Mar 12, 2018 | Option Exercise | $4.21 | 3,500 | 14,735 | 18,528 | Mar 13, 2018, 04:48 PM |
Liu David Y | Chief Scientific Officer | Mar 12, 2018 | Sale | $21.29 | 3,500 | 74,500 | 15,028 | Mar 13, 2018, 04:48 PM |
Liu David Y | Chief Scientific Officer | Mar 02, 2018 | Option Exercise | $1.89 | 875 | 1,654 | 14,197 | Mar 02, 2018, 07:17 PM |
Liu David Y | Chief Scientific Officer | Mar 02, 2018 | Sale | $20.00 | 875 | 17,500 | 13,322 | Mar 02, 2018, 07:17 PM |
Liu David Y | Chief Scientific Officer | Jan 16, 2018 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Jan 17, 2018, 04:34 PM |
Liu David Y | Chief Scientific Officer | Jan 16, 2018 | Sale | $20.00 | 875 | 17,500 | 3,822 | Jan 17, 2018, 04:34 PM |
Shames Richard S. | Chief Medical Officer | Dec 22, 2017 | Option Exercise | $4.21 | 3,529 | 14,857 | 3,529 | Dec 27, 2017, 02:07 PM |
Shames Richard S. | Chief Medical Officer | Dec 22, 2017 | Sale | $20.50 | 3,529 | 72,345 | 0 | Dec 27, 2017, 02:07 PM |
PATEL DINESH V PH D | President and CEO | Dec 21, 2017 | Option Exercise | $1.89 | 8,210 | 15,517 | 198,647 | Dec 21, 2017, 07:54 PM |
PATEL DINESH V PH D | President and CEO | Dec 21, 2017 | Sale | $19.56 | 8,210 | 160,570 | 190,437 | Dec 21, 2017, 07:54 PM |
PATEL DINESH V PH D | President and CEO | Dec 20, 2017 | Option Exercise | $1.89 | 1,790 | 3,383 | 192,227 | Dec 20, 2017, 09:28 PM |
PATEL DINESH V PH D | President and CEO | Dec 20, 2017 | Sale | $19.55 | 1,790 | 34,987 | 190,437 | Dec 20, 2017, 09:28 PM |
Liu David Y | Chief Scientific Officer | Dec 18, 2017 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Dec 20, 2017, 09:13 PM |
Liu David Y | Chief Scientific Officer | Dec 18, 2017 | Sale | $20.00 | 875 | 17,500 | 3,822 | Dec 20, 2017, 09:13 PM |
O'Neil Thomas P. | Chief Financial Officer | Dec 18, 2017 | Option Exercise | $2.69 | 8,000 | 21,480 | 8,000 | Dec 20, 2017, 09:08 PM |
O'Neil Thomas P. | Chief Financial Officer | Dec 18, 2017 | Sale | $20.00 | 8,000 | 160,000 | 0 | Dec 20, 2017, 09:08 PM |
Liu David Y | Chief Scientific Officer | Nov 30, 2017 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Dec 01, 2017, 06:56 PM |
Liu David Y | Chief Scientific Officer | Nov 30, 2017 | Sale | $20.00 | 875 | 17,500 | 3,822 | Dec 01, 2017, 06:56 PM |
Liu David Y | Chief Scientific Officer | Nov 13, 2017 | Option Exercise | $3.05 | 7,000 | 21,350 | 7,322 | Nov 15, 2017, 07:14 PM |
Liu David Y | Chief Scientific Officer | Nov 13, 2017 | Sale | $16.97 | 7,000 | 118,761 | 3,822 | Nov 15, 2017, 07:14 PM |
Shames Richard S. | Chief Medical Officer | Oct 05, 2017 | Option Exercise | $4.21 | 2,017 | 8,492 | 2,017 | Oct 10, 2017, 07:04 PM |
Shames Richard S. | Chief Medical Officer | Oct 05, 2017 | Sale | $19.00 | 2,017 | 38,323 | 0 | Oct 10, 2017, 07:04 PM |
Shames Richard S. | Chief Medical Officer | Sep 12, 2017 | Sale | $14.31 | 3,687 | 52,753 | 0 | Sep 12, 2017, 07:50 PM |
Shames Richard S. | Chief Medical Officer | Aug 29, 2017 | Option Exercise | $4.21 | 1,512 | 6,366 | 3,377 | Aug 30, 2017, 07:08 PM |
Shames Richard S. | Chief Medical Officer | Aug 29, 2017 | Sale | $17.00 | 1,512 | 25,704 | 1,865 | Aug 30, 2017, 07:08 PM |
Liu David Y | Chief Scientific Officer | Aug 28, 2017 | Option Exercise | $4.21 | 3,500 | 14,735 | 5,500 | Aug 29, 2017, 07:48 PM |
Liu David Y | Chief Scientific Officer | Aug 28, 2017 | Sale | $15.00 | 3,500 | 52,500 | 2,000 | Aug 29, 2017, 07:48 PM |
Liu David Y | Chief Scientific Officer | Jul 10, 2017 | Option Exercise | $1.89 | 3,500 | 6,615 | 5,500 | Jul 12, 2017, 05:55 PM |
Liu David Y | Chief Scientific Officer | Jul 10, 2017 | Sale | $12.68 | 3,500 | 44,380 | 2,000 | Jul 12, 2017, 05:55 PM |
PATEL DINESH V PH D | President and CEO | May 09, 2017 | Option Exercise | $1.16 | 19,099 | 22,155 | 190,437 | May 10, 2017, 08:44 PM |
PATEL DINESH V PH D | President and CEO | Apr 06, 2017 | Option Exercise | $1.16 | 20,000 | 23,200 | 171,338 | Apr 07, 2017, 09:24 PM |
PATEL DINESH V PH D | President and CEO | Mar 10, 2017 | Option Exercise | $0.87 | 16,362 | 14,235 | 151,338 | Mar 13, 2017, 07:24 PM |
JOHNSON & JOHNSON | 10% Owner | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,449,183 | Aug 18, 2016, 05:11 PM |
Papanek Julie | Director | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,453,255 | Aug 16, 2016, 06:30 PM |
CANAAN X L.P. | Director | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,453,255 | Aug 16, 2016, 06:28 PM |
Shanafelt Armen | Director | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,099,482 | Aug 16, 2016, 06:20 PM |
LV Management Group, LLC | 10% Owner | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,099,482 | Aug 16, 2016, 06:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Ali Asif | Chief Financial Officer | 04/18/2024 | 30,986 |
PATEL DINESH V PH D | President and CEO | 04/01/2024 | 707,750 |
SELICK HAROLD E | Director | 03/07/2024 | 12,266 |
PATEL DINESH V PH D | President and CEO | 03/01/2024 | 948,600 |
Waddill William D. | Director | 03/01/2024 | 79,018 |
Waddill William D. | Director | 03/01/2024 | 406,637 |
Ali Asif | Chief Financial Officer | 03/01/2024 | 146,040 |
Ali Asif | Chief Financial Officer | 03/01/2024 | 459,318 |
Ali Asif | Chief Financial Officer | 02/29/2024 | 305,048 |
PATEL DINESH V PH D | President and CEO | 02/26/2024 | 322,320 |
Gupta Suneel | Chief Development Officer | 02/26/2024 | 126,447 |
PATEL DINESH V PH D | President and CEO | 02/15/2024 | 104,931 |
MOLINA ARTURO MD | Chief Medical Officer | 01/16/2024 | 10,517 |
Ali Asif | Chief Financial Officer | 01/16/2024 | 35,763 |
Gupta Suneel | Chief Development Officer | 01/09/2024 | 36,900 |
Gupta Suneel | Chief Development Officer | 01/09/2024 | 125,000 |
MOLINA ARTURO MD | Chief Medical Officer | 11/15/2023 | 30,012 |
PATEL DINESH V PH D | President and CEO | 12/13/2023 | 1,506,000 |
Gupta Suneel | Chief Development Officer | 10/19/2023 | 147,600 |
PATEL DINESH V PH D | President and CEO | 10/18/2023 | 25,260 |
Gupta Suneel | Chief Development Officer | 05/31/2023 | 108,190 |
PATEL DINESH V PH D | President and CEO | 05/31/2023 | 317,142 |
Ali Asif | Chief Financial Officer | 05/31/2023 | 108,190 |
Ali Asif | Chief Financial Officer | 04/18/2023 | 27,597 |
SELICK HAROLD E | Director | 04/10/2023 | 5,391 |
Liu David Y | Chief R&D Strategy Officer | 11/16/2022 | 231,802 |
PATEL DINESH V PH D | President and CEO | 08/23/2022 | 84,200 |
Waddill William D. | Director | 05/03/2022 | 103,080 |
PATEL DINESH V PH D | President and CEO | 05/04/2022 | 66,274 |
Gupta Suneel | Chief Development Officer | 04/26/2022 | 295,200 |
PATEL DINESH V PH D | President and CEO | 04/26/2022 | 126,300 |
PATEL DINESH V PH D | President and CEO | 04/14/2022 | 64,424 |
Gupta Suneel | Chief Development Officer | 02/28/2022 | 15,758 |
PATEL DINESH V PH D | President and CEO | 02/28/2022 | 112,853 |
Liu David Y | Chief Scientific Officer | 02/28/2022 | 51,449 |
PATEL DINESH V PH D | President and CEO | 12/21/2021 | 482,170 |
PATEL DINESH V PH D | President and CEO | 09/21/2021 | 168,400 |
Liu David Y | Chief Scientific Officer | 08/17/2021 | 8,700 |
Liu David Y | Chief Scientific Officer | 08/17/2021 | 702,889 |
Noonberg Sarah B. | Director | 02/10/2021 | 32,806 |
Noonberg Sarah B. | Director | 02/11/2021 | 25,826 |
Noonberg Sarah B. | Director | 02/10/2021 | 119,722 |
Noonberg Sarah B. | Director | 02/11/2021 | 92,833 |
PATEL DINESH V PH D | President and CEO | 01/19/2021 | 54,730 |
PATEL DINESH V PH D | President and CEO | 01/19/2021 | 611,105 |
KHOSLA CHAITAN PHD | Director | 08/11/2020 | 4,723 |
KHOSLA CHAITAN PHD | Director | 08/11/2020 | 42,952 |
PATEL DINESH V PH D | President and CEO | 03/20/2020 | 18,900 |
PATEL DINESH V PH D | President and CEO | 03/12/2020 | 21,279 |
SELICK HAROLD E | Director | 03/12/2020 | 80,400 |
Giraudo Bryan | Director | 12/03/2019 | 45,620 |
Gupta Suneel | EVP Clinical Operations | 12/03/2019 | 153,900 |
Kalkofen Donald A. | Chief Financial Officer | 12/03/2019 | 5,987 |
PATEL DINESH V PH D | President and CEO | 12/03/2019 | 168,500 |
PATEL DINESH V PH D | President and CEO | 11/26/2019 | 4,640 |
Liu David Y | Chief Scientific Officer | 08/06/2019 | 30,044 |
PATEL DINESH V PH D | President and CEO | 08/06/2019 | 95,535 |
SELICK HAROLD E | Director | 04/01/2019 | 4,336 |
Liu David Y | Chief Scientific Officer | 03/01/2019 | 6,504 |
PATEL DINESH V PH D | President and CEO | 03/01/2019 | 17,529 |
Shames Richard S. | Chief Medical Officer | 03/01/2019 | 5,276 |
PATEL DINESH V PH D | President and CEO | 02/06/2019 | 84,410 |
Liu David Y | Chief Scientific Officer | 02/06/2019 | 29,562 |
Shames Richard S. | Chief Medical Officer | 02/06/2019 | 21,506 |
PATEL DINESH V PH D | President and CEO | 01/11/2019 | 25,919 |
CANAAN X L.P. | 10% Owner | 05/17/2018 | 237,358 |
Giraudo Bryan | Director | 05/16/2017 | 64,566 |
CANAAN X L.P. | 10% Owner | 05/14/2018 | 494,224 |
CANAAN X L.P. | 10% Owner | 05/16/2018 | 190,071 |
CANAAN X L.P. | 10% Owner | 05/15/2018 | 374,080 |
PATEL DINESH V PH D | President and CEO | 05/10/2018 | 15,679 |
PATEL DINESH V PH D | President and CEO | 04/02/2018 | 23,200 |
PATEL DINESH V PH D | President and CEO | 03/26/2018 | 9,829 |
CANAAN X L.P. | 10% Owner | 03/23/2018 | 1,241,325 |
CANAAN X L.P. | 10% Owner | 03/21/2018 | 364,727 |
CANAAN X L.P. | 10% Owner | 03/20/2018 | 351,538 |
CANAAN X L.P. | 10% Owner | 03/22/2018 | 98,133 |
CANAAN X L.P. | 10% Owner | 03/19/2018 | 276,446 |
CANAAN X L.P. | 10% Owner | 03/16/2018 | 142,063 |
CANAAN X L.P. | 10% Owner | 03/13/2018 | 25,094 |
CANAAN X L.P. | 10% Owner | 03/15/2018 | 242,521 |
CANAAN X L.P. | 10% Owner | 03/14/2018 | 4,154 |
Liu David Y | Chief Scientific Officer | 03/12/2018 | 14,735 |
Liu David Y | Chief Scientific Officer | 03/12/2018 | 74,500 |
Liu David Y | Chief Scientific Officer | 03/02/2018 | 1,654 |
Liu David Y | Chief Scientific Officer | 03/02/2018 | 17,500 |
Liu David Y | Chief Scientific Officer | 01/16/2018 | 1,654 |
Liu David Y | Chief Scientific Officer | 01/16/2018 | 17,500 |
Shames Richard S. | Chief Medical Officer | 12/22/2017 | 14,857 |
Shames Richard S. | Chief Medical Officer | 12/22/2017 | 72,345 |
PATEL DINESH V PH D | President and CEO | 12/21/2017 | 15,517 |
PATEL DINESH V PH D | President and CEO | 12/21/2017 | 160,570 |
PATEL DINESH V PH D | President and CEO | 12/20/2017 | 3,383 |
PATEL DINESH V PH D | President and CEO | 12/20/2017 | 34,987 |
Liu David Y | Chief Scientific Officer | 12/18/2017 | 1,654 |
Liu David Y | Chief Scientific Officer | 12/18/2017 | 17,500 |
O'Neil Thomas P. | Chief Financial Officer | 12/18/2017 | 21,480 |
O'Neil Thomas P. | Chief Financial Officer | 12/18/2017 | 160,000 |
Liu David Y | Chief Scientific Officer | 11/30/2017 | 1,654 |
Liu David Y | Chief Scientific Officer | 11/30/2017 | 17,500 |
Liu David Y | Chief Scientific Officer | 11/13/2017 | 21,350 |
Liu David Y | Chief Scientific Officer | 11/13/2017 | 118,761 |
Shames Richard S. | Chief Medical Officer | 10/05/2017 | 8,492 |
Shames Richard S. | Chief Medical Officer | 10/05/2017 | 38,323 |
Shames Richard S. | Chief Medical Officer | 09/12/2017 | 52,753 |
Shames Richard S. | Chief Medical Officer | 08/29/2017 | 6,366 |
Shames Richard S. | Chief Medical Officer | 08/29/2017 | 25,704 |
Liu David Y | Chief Scientific Officer | 08/28/2017 | 14,735 |
Liu David Y | Chief Scientific Officer | 08/28/2017 | 52,500 |
Liu David Y | Chief Scientific Officer | 07/10/2017 | 6,615 |
Liu David Y | Chief Scientific Officer | 07/10/2017 | 44,380 |
PATEL DINESH V PH D | President and CEO | 05/09/2017 | 22,155 |
PATEL DINESH V PH D | President and CEO | 04/06/2017 | 23,200 |
PATEL DINESH V PH D | President and CEO | 03/10/2017 | 14,235 |
JOHNSON & JOHNSON | 10% Owner | 08/16/2016 | 6,999,996 |
Papanek Julie | Director | 08/16/2016 | 6,999,996 |
CANAAN X L.P. | Director | 08/16/2016 | 6,999,996 |
Shanafelt Armen | Director | 08/16/2016 | 6,999,996 |
LV Management Group, LLC | 10% Owner | 08/16/2016 | 6,999,996 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PROTAGONIST THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
FARALLON CAPITAL MANAGEMENT LLC | 5,734,430 | 0.65% | 5.29% | Event Driven, Value |
BLACKROCK INC. | 5,543,902 | 0.00324% | 6.01% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,291,701 | 0.06% | 84.53% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,248,284 | 0.00299% | 5.67% | Other |
CANDRIAM S.C.A. | 537,000 | 0.08% | -14.76% | Other |
RENAISSANCE TECHNOLOGIES LLC | 213,967 | 0.00759% | -5.44% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 198,689 | 0.05% | New | Growth |
UBS OCONNOR LLC | 106,154 | 0.18% | -22.1% | Value |
BALYASNY ASSET MANAGEMENT L.P. | 50,503 | 0.00217% | New | Event Driven |
ALPS ADVISORS INC | 40,072 | 0.00722% | -5.6% | Other |
TUDOR INVESTMENT CORP ET AL | 28,786 | 0.00532% | New | Event Driven, Other |
AQR CAPITAL MANAGEMENT LLC | 9,342 | 0.0004% | -10.74% | Other |
CHANGE IN SHARES OUTSTANDING FOR PROTAGONIST THERAPEUTICS INC
STOCK BUYBACKS FOR PROTAGONIST THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
2.10%
1Q
06/30/2023
6.43%
2Q
03/31/2023
19.48%
3Q
12/31/2022
22.68%
4Q
09/30/2022
23.05%
5Q
06/30/2022
23.19%
6Q
03/31/2022
23.95%
7Q
12/31/2021
25.43%
8Q
09/30/2021
25.92%
9Q
06/30/2021
34.69%
10Q
03/31/2021
36.64%
11Q
12/31/2020
52.43%
12Q
09/30/2020
61.63%
13Q
06/30/2020
84.23%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PROTAGONIST THERAPEUTICS INC
LOADING...